Stock A214610 MICO BIOMED CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News MiCo BioMed Co., Ltd.

Equities

A214610

KR7214610008

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-06-06 EDT 		5-day change 1st Jan Change
1,376 KRW -1.01% Intraday chart for MiCo BioMed Co., Ltd. -0.79% -25.70%
2023 MiCo BioMed Co., Ltd.(KOSDAQ:A214610) dropped from S&P Global BMI Index CI
2023 Miko Co., Ltd. entered a stock purchase contract to acquire an additional 2.77% stake in MiCo BioMed Co., Ltd. from KoMiCo Ltd. for KRW 2.6 billion. CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
MiCo BioMed Co., Ltd.(KOSDAQ:A214610) dropped from S&P Global BMI Index
CI
Miko Co., Ltd. entered a stock purchase contract to acquire an additional 2.77% stake in MiCo BioMed Co., Ltd. from KoMiCo Ltd. for KRW 2.6 billion.
CI
MiCo BioMed Co., Ltd. announced that it has received KRW 9 billion in funding
CI
MiCo BioMed Co., Ltd. announced that it expects to receive KRW 9 billion in funding
CI
MiCo BioMed Co., Ltd. announced that it has received KRW 20 billion in funding
CI
MiCo BioMed Co., Ltd. announced that it expects to receive KRW 20 billion in funding
CI
MiCo BioMed Co., Ltd.(KOSDAQ:A214610) added to S&P Global BMI Index
CI
Speclipse, Inc. announced that it has received $7.7 million in funding from S'ignite Partners Co., Ltd., BNH Investment LLC, Shinhan Capital Co., Ltd., MiCo Ltd., MiCo BioMed Co., Ltd.
CI
MiCo BioMed Co., Ltd. announced that it has received KRW 5 billion in funding
CI
MiCo BioMed Co., Ltd. announced that it expects to receive KRW 5 billion in funding
CI
MiCo BioMed Co., Ltd. cancelled the acquisition of Siloam Biosciences, Inc from a group of shareholders.
CI
MiCo BioMed Co., Ltd. agreed to acquire 98.3% stake in Siloam Biosciences, Inc from a group of shareholders for KRW 5.1 billion.
CI
MiCo BioMed Co., Ltd. announced that it has received KRW 5 billion in funding
CI
Sunkyu Jeon acquired an additional 4.2% stake in MiCo BioMed Co., Ltd. from Sungwoo Kim for KRW 2.9 billion.
CI
MiCo BioMed Co., Ltd. announced that it expects to receive KRW 5 billion in funding
CI
Nanobiosys Inc. completed the acquisition of Micobiomed Co., Ltd. from MiCo Ltd., Sun-Kyu Jeon, Byungseung Kang and others.
CI
MiCo NanoBioSys Co., Ltd.'s Equity Buyback announced on August 31, 2017 has expired.
CI
Nanobiosys Inc. announces an Equity Buyback.
CI
Nanobiosys Inc. authorizes a Buyback Plan.
CI
Nanobiosys Inc. signed a merger contract to acquire Micobiomed Co., Ltd. from MiCo Ltd., Sun-Kyu Jeon, Byungseung Kang and others for KRW 35.3 billion.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A214610 Stock
  4. News MiCo BioMed Co., Ltd.